COMPOUND PROFILE / PEPTIDES & ANALOGUES
VIP / Vasoactive Intestinal Peptide.
Research draftVIP is vasoactive intestinal peptide, an endogenous signalling peptide; synthetic VIP is also called aviptadil.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
VIP is vasoactive intestinal peptide, an endogenous signalling peptide; synthetic VIP is also called aviptadil.
Mechanism
It activates VIP receptors affecting vascular tone, secretion and immune signalling.
Human research
Human physiological studies and disease trials exist. Outcomes are route- and disease-specific.
Preclinical & other research
Laboratory research explores immune and respiratory effects.
Safety & unknowns
Flushing, haemodynamic effects and other systemic responses matter; route-specific monitoring is important.
Regulatory status
Cross-link Aviptadil without counting the same trials twice; no general wellness indication is established.
Reported use & evidence
The supplied VIP / Vasoactive Intestinal Peptide profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.